AKR1C3 and posterior cortical atrophy: In addition, AKR1C3 overexpression increased the resistance of PCa cells to enzalutamide, abiraterone and chemotherapy drugs, which was reversed by indomethacin, a nonspecific inhibitor of AKR1C3 (22, 25).